About Basilisk
Basilisk is a company based in Delft (Netherlands) founded in 2015. It operates as a Direct-to-Consumer (D2C) and B2B2C. Basilisk offers products and services including Basilisk Healing Agent, Basilisk Repair Mortar MR3, and Basilisk Liquid Repair System ER7. Basilisk operates in a competitive market with competitors including BioSapien and Mimicrete, among others.
- Headquarter Delft, Netherlands
-
Sectors
Real Estate & ConstructionChemicals & Materials
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$68.69 K (USD), Grant
Mar 01, 2023
-
Investors
European Union
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Basilisk
Basilisk offers a comprehensive portfolio of products and services, including Basilisk Healing Agent, Basilisk Repair Mortar MR3, and Basilisk Liquid Repair System ER7.
Used to enable self-healing in new concrete mixes.
Applied for repairing cracks in existing concrete structures.
Utilized for sealing cracks in existing concrete constructions.
Funding Insights of Basilisk
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $68,693
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Grant - Basilisk | Valuation |
investors |
|
| Nov, 2017 | Amount | Seed - Basilisk | Valuation |
investors |
Investors in Basilisk
Basilisk has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and SHIFT Invest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage impact investments are focused on Dutch companies.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
Investments & Acquisitions by Basilisk
Financial Statements - Basilisk
Basilisk Comparisons
Latest news on Basilisk
Frequently Asked Questions about Basilisk
Basilisk was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Basilisk is headquartered in Delft, Netherlands. It is registered at Delft, South Holland, Netherlands.
Bart Woerd is the current CEO of Basilisk.
Basilisk is focused on the development and provision of bio-based self-healing concrete products. These solutions are designed to enhance the durability and waterproofing of concrete structures. The technology utilizes microorganisms to produce limestone, autonomously repairing cracks in both new and existing concrete constructions. Sectors served include construction and infrastructure, with products applicable to water treatment plants and roadways. Benefits include reduced maintenance costs, extended lifespan of structures, and a significant reduction in CO2 footprint by 30-50.
Basilisk offers Basilisk Healing Agent, Basilisk Repair Mortar MR3, and Basilisk Liquid Repair System ER7.
Basilisk has 2 investors. Key investors include European Union, and SHIFT Invest.